1. Home
  2. WOK vs MGX Comparison

WOK vs MGX Comparison

Compare WOK & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOK
  • MGX
  • Stock Information
  • Founded
  • WOK 2002
  • MGX 2018
  • Country
  • WOK China
  • MGX United States
  • Employees
  • WOK N/A
  • MGX N/A
  • Industry
  • WOK
  • MGX
  • Sector
  • WOK
  • MGX
  • Exchange
  • WOK NYSE
  • MGX NYSE
  • Market Cap
  • WOK 79.5M
  • MGX 70.4M
  • IPO Year
  • WOK 2024
  • MGX 2024
  • Fundamental
  • Price
  • WOK $4.97
  • MGX $3.55
  • Analyst Decision
  • WOK
  • MGX Strong Buy
  • Analyst Count
  • WOK 0
  • MGX 7
  • Target Price
  • WOK N/A
  • MGX $16.67
  • AVG Volume (30 Days)
  • WOK 161.9K
  • MGX 4.5M
  • Earning Date
  • WOK 02-03-2025
  • MGX 02-12-2025
  • Dividend Yield
  • WOK N/A
  • MGX N/A
  • EPS Growth
  • WOK N/A
  • MGX N/A
  • EPS
  • WOK N/A
  • MGX N/A
  • Revenue
  • WOK $9,863,642.00
  • MGX $55,080,000.00
  • Revenue This Year
  • WOK N/A
  • MGX $11.59
  • Revenue Next Year
  • WOK N/A
  • MGX N/A
  • P/E Ratio
  • WOK N/A
  • MGX N/A
  • Revenue Growth
  • WOK N/A
  • MGX 45.13
  • 52 Week Low
  • WOK $3.26
  • MGX $1.61
  • 52 Week High
  • WOK $8.45
  • MGX $12.74
  • Technical
  • Relative Strength Index (RSI)
  • WOK N/A
  • MGX 64.37
  • Support Level
  • WOK N/A
  • MGX $2.91
  • Resistance Level
  • WOK N/A
  • MGX $3.63
  • Average True Range (ATR)
  • WOK 0.00
  • MGX 0.54
  • MACD
  • WOK 0.00
  • MGX 0.09
  • Stochastic Oscillator
  • WOK 0.00
  • MGX 55.66

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

Share on Social Networks: